Cancer Institute Clinical Trials - Breast

Adjuvant Note Positive, Node Negative, Unknown

#71430NCT00433511
Title: A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer (NCI CIRB)
Study Location: Temple Main Campus

#81958NCT00769379
Title: A Phase III Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiatin Theray Aloone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy
Study Location: Temple Main Campus

Metastatic

#110725 NCT01491737
Title: A randomized, two-arm, open-label, multicenter Phase II trial assessing the efficacy and safety of pertuzumab given in combination with trastuzumab plus an aromatase inhibitor in first line patients with HER2-positive and hormone receptor-positive advanced (metastatic or locally advanced) breast cancer (PERTAIN)
Study Location: Temple Main Campus

#60793 NCT00382018
Title: A Randomized Phase III Trial to Test the Strategy of Changing Therapy Versus Maintaining therapy for Metastatic Breast Cancer Patients Who Have Elevated Circulating Tumor Cell Levels at the First Follow-Up Assessment
Study Location: Temple Main Campus

For more information or to enroll in a study please call: 1-254-724-5407


Print
Text Size
A
A
A